Fact Sheet: AQUI-S® INAD 10-541

for detailed information, see INAD study protocol, use link on the left

The following links are specific
to: AQUI-S®

Drug summary & history

List of FDA-Approved drugs

Drug forms to be completed

INAD study protocol

Material Safety Data Sheet
(MSDS)

Study Summaries

What's the status of this drug's
approval

Other Federal Guidance

Print this drug fact sheet

Print all drug fact sheets

INAD signup form (Federal facilities)

INAD signup form (other facilities)

Information on EPA's National Pollutant Discharge Elimination System (NPDES) Permits

Objective/purpose: Collect supportive and pivotal data needed to establish the effectiveness of AQUI-S® as an anesthetic for use in a variety of fish species.
Drug name: AQUI-S®
Source of drug: AQUI-S New Zealand, Ltd.
Addre
ALL use of Aqui-S® in food fish is strictly prohibited. To view this fact sheet, select "Print this drug fact sheet" on the left side of this screen.
ss:
P.O Box 818
San Luis Obispo, CA 93406
Contact: Bob Campbell
Phone: 805-542-0871; Fax: 805-542-0891;
email: campbellr@aol.com
Target pathogen(s): Not Applicable
Method of administration: Immersion: standing-bath treatment only
Treatment dosage: 5 - 60 milligrams AQUI-S® per liter
Treatment regimen: Treatment duration is 1 - 60 minutes. Treatment duration will vary dependent upon species, water temperature, and level of anesthesia desired.
AQUI-S® should be applied as a single treatment event.
Withdrawal period: 21 days
Required test parameters: Investigator must collect data documenting: 1) time to anesthesia; and 2) time to recovery from anesthesia. Investigator should also report general fish behavior and any adverse effects relating to treatment.
Limitations or restrictions on use: Treatment is restricted to anesthetic tanks containing a maximum of 75 gallons of water.

Investigator must follow all instructions in the Study Protocol for INAD 10-541 regarding drug acquisition and handling, fish treatment and disposition, and data reporting requirements.

Drug discharge must be in compliance with local NPDES permitting requirements.
Required INAD fee: none
AADAP contact for other information: Ms. Bonnie Johnson, FWS - AADAP
Phone: 406-587-9265 ext. 136
Fax: 406-582-0242

bonnie_johnson@fws.gov
Disclaimer: Product and company names mentioned in this website, or mentioned in materials accessed via this website, are for informational purposes only. The mention of such does not imply endorsement by the Aquatic Animal Drug Approval Partnership, the U.S. Fish & Wildlife Service or any other organization of the U.S. Government.